Cita APA

Dayyani, F., Zurita, A. J., Nogueras-González, G. M., Slack, R., Millikan, R. E., Araujo, J. C., . . . Corn, P. G. (2016). The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study. BMC Cancer.

Chicago Style Citation

Dayyani, Farshid, Amado J. Zurita, Graciela M. Nogueras-González, Rebecca Slack, Randall E. Millikan, John C. Araujo, Gary E. Gallick, Christopher J. Logothetis, i Paul G. Corn. "The Combination of Serum Insulin, Osteopontin, and Hepatocyte Growth Factor Predicts Time to Castration-resistant Progression in Androgen Dependent Metastatic Prostate Cancer- an Exploratory Study." BMC Cancer 2016.

Cita MLA

Dayyani, Farshid, et al. "The Combination of Serum Insulin, Osteopontin, and Hepatocyte Growth Factor Predicts Time to Castration-resistant Progression in Androgen Dependent Metastatic Prostate Cancer- an Exploratory Study." BMC Cancer 2016.